Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Chubb
Julphar
Medtronic
Mallinckrodt
Fuji
Johnson and Johnson
Boehringer Ingelheim
Cerilliant

Generated: December 19, 2018

DrugPatentWatch Database Preview

ACETADOTE Drug Profile

« Back to Dashboard

Which patents cover Acetadote, and what generic alternatives are available?

Acetadote is a drug marketed by Cumberland Pharms and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has seventeen patent family members in ten countries.

The generic ingredient in ACETADOTE is acetylcysteine. There are three drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the acetylcysteine profile page.

Drug patent expirations by year for ACETADOTE
Medical Subject Heading (MeSH) Categories for ACETADOTE
Synonyms for ACETADOTE
(2R)-2-(acetylamino)-3-mercaptopropanoic acid
(2R)-2-(acetylamino)-3-sulfanylpropanoic acid
(2R)-2-[(Z)-(1-hydroxyethylidene)amino]-3-sulfanylpropanoic acid
(2R)-2-Acetamido-3-sulfanyl-propanoic acid
(2R)-2-acetamido-3-sulfanylpropanoic acid
(2R)-2-acetylamino-3-mercapto-propionic acid
(2R)-2-acetylamino-3-sulfanylpropanoic acid
(R)-2-Acetamido-3-mercaptopropanoic acid
(R)-2-acetylamino-3-mercaptopropanoic acid
(R)-mercapturic acid
1-alpha-Acetamido-beta-mercaptopropionic acid
1261105-20-7
16A911
18829-79-3 (hydrochloride)
19542-74-6 (mono-hydrochloride salt)
2-Acetylamino-3-mercapto-propionate
2-Acetylamino-3-mercapto-propionic acid
616-91-1
63664-54-0 (hydrochloride salt)
66233-EP2298305A1
66233-EP2308851A1
7696-05-1
A 7250
A-1100
A0905
AB0013800
AB00382974_13
AB00382974-12
AB1002786
AC-16071
AC-24117
Ac-Cys-OH
AC1L1YP9
AC1Q1K99
AC1Q1K9A
AcCys
Acetadone EF
Acetadote ALF
Acetein
Acetilcisteina
Acetilcisteina [INN-Spanish]
acetilcysteina
acetyl cysteine
Acetyl-L-cysteine
acetylcysteine
Acetylcysteine (JP17/USP/INN)
acetylcysteine (n-acetyl-l-cysteine)
Acetylcysteine [USAN:INN:BAN]
Acetylcysteine [USAN:USP:INN:BAN:JAN]
Acetylcysteine, British Pharmacopoeia (BP) Reference Standard
Acetylcysteine, Cumberland Pharmaceuticals
Acetylcysteine, European Pharmacopoeia (EP) Reference Standard
Acetylcysteine, United States Pharmacopeia (USP) Reference Standard
Acetylcysteinum
Acetylcysteinum [INN-Latin]
Airbron
AJ-45053
AK-46577
AKOS015841009
AM006927
AM010961
AM20100502
AN-769
ANTIOXIDANT MODEL (TRAMP) -N-ACETYLCYSTEINE
ANW-33915
BC209913
BDBM50420190
BP-12854
BR-46577
Broncholysin
Brunac
BSPBio_001794
C06809
CABC898A-E48B-4E13-9F72-98D0609A1854
CAS-616-91-1
CCG-204176
CCRIS 3764
Cetylev
CHEBI:28939
CHEMBL600
component of Naxid
CS-2160
CTK2F2887
cysteine, N-acetyl-
Cysteine, N-acetyl-, L-
D00221
D00OQW
D06XGW
DB-038288
DB06151
DSSTox_CID_21
DSSTox_GSID_20021
DSSTox_RID_75324
DTXSID5020021
EINECS 210-498-3
EN300-72028
EU-0100081
Exomuc
F1905-7178
Fabrol
Fluatox
Fluimicil Infantil
Fluimucetin
Fluimucil
Flumil
Flumucetin
Fluprowit
FT-0629832
GS-3121
HMS2234J22
HMS3260A04
HMS3655G11
HSDB 3003
HY-B0215
I630
Ilube
Inspir
J-507685
KB-47112
KBio3_001294
KBioGR_000554
KS-0000026W
KSC352Q8P
L-.alpha.-Acetamido-.beta.-mercaptopropionic acid
L-Acetylcysteine
L-alpha-Acetamido-beta-mercaptopropionic acid
L-Cysteine, N-acetyl-
L-Cysteine, N-acetyl- & Tumor necrosis factor
LNAC
LNAC; NAC,L-alpha-Acetamido-beta-mercaptopropionic acid; Mercapturic acid
Lopac0_000081
LP00081
LS-2165
Lysomucil
Lysox
mercapturic acid
Mercapturic acid, (R)-
MFCD00004880
MLS000028419
MLS001076125
MLS006011563
MolPort-000-150-826
Muco sanigen
Mucocedyl
Mucofilin
Mucolator
Mucolyticum
Mucolyticum Lappe
Mucolyticum-Lappe
Mucolytikum Lappe
Mucomyst
MUCOMYST (TN)
Mucosil
MUCOSIL-10
MUCOSIL-20
Mucosolvin
Mucret
N-Acety-L-Cysteine
N-Acetyl cysteine
N-acetyl-(R)-cysteine
N-Acetyl-3-mercaptoalanine
N-Acetyl-cysteine
N-Acetyl-L-(+)-cysteine
N-acetyl-l-cys
N-acetyl-L-cystein
N-Acetyl-L-cysteine
N-Acetyl-L-cysteine & Tumor necrosis factor (TNF)
N-Acetyl-L-cysteine, BioXtra, >=99% (TLC)
N-Acetyl-L-cysteine, cell culture tested, BioReagent
N-Acetyl-L-cysteine, pharmaceutical secondary standard; traceable to USP, PhEur and BP
N-Acetyl-L-cysteine, PharmaGrade, Ajinomoto, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture
N-Acetyl-L-cysteine, SAJ special grade, 98.0-102.0%
N-Acetyl-L-cysteine, Sigma Grade, >=99% (TLC), powder
N-Acetyl-L-cysteine, Vetec(TM) reagent grade, 98%
N-Acetyl-N-Cysteine
N-acetylcystein
N-Acetylcysteine
NAC
NAC & TNF
NAC-TB
Naxid (Salt/Mix)
NCGC00015086-04
NCGC00022304-03
NCGC00022304-04
NCGC00022304-05
NCGC00022304-06
NCGC00022304-07
NCGC00022304-08
NCGC00258631-01
NCGC00260766-01
Neo-fluimucil
NSC 111180
NSC-111180
NSC111180
Opera_ID_452
Parvolex
PubChem12963
PWKSKIMOESPYIA-BYPYZUCNSA-N
RAC-(2R)-2-ACETAMIDO-3-SULFANYLPROPANOIC ACID
Respaire
RK-0202
RP22622
RTC-066653
s1623
SC-09436
SC2
SCHEMBL5292
SMR000058377
Sodium 2-acetamido-3-mercaptopropionate
SPBio_000012
Spectrum2_000086
Spectrum3_000287
Spectrum4_000137
Spectrum5_000764
SR-01000075439
SR-01000075439-1
ST2408139
ST50824849
Syntemucol
TC-066653
Tixair
TL8003928
Tox21_110877
Tox21_110877_1
Tox21_201078
Tox21_500081
UNII-WYQ7N0BPYC
WYQ7N0BPYC
ZINC3589203

US Patents and Regulatory Information for ACETADOTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cumberland Pharms ACETADOTE acetylcysteine INJECTABLE;INTRAVENOUS 021539-001 Jan 23, 2004 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cumberland Pharms ACETADOTE acetylcysteine INJECTABLE;INTRAVENOUS 021539-001 Jan 23, 2004 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cumberland Pharms ACETADOTE acetylcysteine INJECTABLE;INTRAVENOUS 021539-001 Jan 23, 2004 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cumberland Pharms ACETADOTE acetylcysteine INJECTABLE;INTRAVENOUS 021539-001 Jan 23, 2004 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cumberland Pharms ACETADOTE acetylcysteine INJECTABLE;INTRAVENOUS 021539-001 Jan 23, 2004 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for ACETADOTE
Drugname Dosage Strength RLD Date
➤ Subscribe Injection 200 mg/mL, 30 mL vials ➤ Subscribe ➤ Try a Free Trial

International Patents for ACETADOTE

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Chubb
Julphar
Medtronic
Mallinckrodt
Fuji
Johnson and Johnson
Boehringer Ingelheim
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.